Delivery Order SPE2DB25D3021-SPE2DB25FQZGL
- Not listed
- The Defense Logistics Agency awarded a $3,392.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of FORTEO (560 mcg/2.24 mL pen injections). This is a non-set-aside contract with an ultimate completion date of August 4, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is a prescription medication used primarily for treating osteoporosis in patients at high risk for fractures. This delivery order is...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a delivery order valued at $3,513.76 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate offices in...
- This is a $17,182.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The delivery order has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used in the treatment of osteoporosis. The contract has a ceiling value of $9,244.44 and a period of performance through May 30, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there are no noted major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injection) with a ceiling value of $8,274.44. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this...
- This is a $7,804.29 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used to treat osteoporosis. The contract has an ultimate completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
- This is a $4,353.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This is a $14,507.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used to treat osteoporosis. The contract has an ultimate completion date of May 29, 2025 and is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,893.04, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The contract has a firm fixed price pricing type and an ultimate completion date of February 26, 2025. This delivery order is part of a larger Indefinite Delivery...
- SPE2DB25D3021Indefinite Delivery Contract
- SPE2DB25D3021-SPE2DB25FQZGLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,499.08 to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 ml pen injections) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is an FDA-approved pharmaceutical treatment for osteoporosis and bone-related conditions, commonly utilized within military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, medical devices, and healthcare commodities to military healthcare programs worldwide. The contract supports multiple government customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 8/13/25 |